Prothena Corp. plc buy Chardan Capital
Start price
21.02.25
/
50%
€16.20
Target price
21.02.26
€38.18
Performance (%)
-54.01%
Price
03.02.26
€7.45
Summary
This prediction is currently active. Massive losses of -54.01% have been the result for the BUY prediction by Chardan_Capital. This prediction currently runs until 21.02.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Prothena Corp. plc | -8.025% | -8.025% |
| iShares Core DAX® | -0.559% | 0.738% |
| iShares Nasdaq 100 | -0.566% | -0.324% |
| iShares Nikkei 225® | 1.073% | 5.624% |
| iShares S&P 500 | 0.868% | 0.030% |
Comments by Chardan_Capital for this prediction
In the thread Prothena Corp. plc diskutieren
Prothena Co. plc (NASDAQ: PRTA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $40.00 price target on the stock.
Ratings data for PRTA provided by MarketBeat
Stopped prediction by Chardan_Capital for Prothena Corp. plc
Prothena Corp. plc
Start price
Target price
Perf. (%)
€6.25
05.08.25
05.08.25
€15.57
05.08.26
05.08.26
19.20%
03.02.26
03.02.26
Prothena Corp. plc
Start price
Target price
Perf. (%)
€4.64
27.05.25
27.05.25
€15.80
27.05.26
27.05.26
60.56%
03.02.26
03.02.26
Prothena Corp. plc
Start price
Target price
Perf. (%)
€14.50
20.12.24
20.12.24
€38.43
20.12.25
20.12.25
-45.86%
21.12.25
21.12.25